Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-014354

IMMUNOGEN INC · IMGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
Oct 30, 2015
Accepted (ET)
Nov 3, 2015 · 12:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockOct 30, 2015M5,575$4.29A159,690D
Common StockOct 30, 2015M122$5.77A159,812D
Common StockF1Nov 2, 2015M5,497$3.19A165,309D
Common StockF1Nov 2, 2015S5,497$12.00D159,812D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F3$4.29Oct 30, 2015M5,575DJan 1, 2010Jan 1, 2019Common Stock5,575194,425D
Stock Option (right to buy)F4$5.77Oct 30, 2015M122DJun 12, 2008Jun 12, 2017Common Stock12262,669D
Stock Option (right to buy)F2$3.19Nov 2, 2015M5,497DJun 8, 2007Jun 8, 2016Common Stock5,49737,917D

Explanation of responses